Combined Cognitive-Behavioral Therapy and Placebo Treatment for Patients with Depression: A Follow-Up Assessment
Authors Schienle A, Jurinec N
Received 1 December 2020
Accepted for publication 19 January 2021
Published 22 February 2021 Volume 2021:14 Pages 233—238
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Igor Elman
Anne Schienle,1 Nina Jurinec1,2
1 Instiute of Psychology, University of Graz, Graz, Austria; 2Community Health Center Gornja Radgona, Gornja Radgona, Slovenia
Correspondence: Anne Schienle Instiute of Psychology, University of Graz, Universitätsplatz 2, Graz, 8010, Austria
Introduction: A previous study revealed that patients with depression who received a combination of cognitive-behavioral therapy (CBT) and placebo treatment (CBT+placebo) showed greater symptom reduction than a CBT group without a placebo. Moreover, the CBT+placebo group practiced relaxation training more frequently. We conducted a 3-month follow-up assessment to investigate the temporal stability of the placebo effects.
Methods: Eighty-two outpatients with a diagnosis of major depressive disorder who had participated in a 4-week CBT course (CBT: n = 40; CBT with daily placebo treatment: n = 42) returned to a 3-month follow-up assessment. The participants of the CBT+placebo group had been debriefed directly after the course.
Results: Compared to the CBT group, the CBT+placebo group had lower scores on the Beck Depression Inventory-II (BDI-II) at follow-up and more participants were below the clinical cut-off score of the BDI-II. Additionally, the CBT+placebo group continued to practice relaxation more frequently.
Discussion: This study demonstrates that placebo effects are not short-lived and continue to be present after the debriefing.
Keywords: placebo effects, temporal stability, depression, cognitive-behavioral therapy
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]